Skip to main content
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
11.62
+0.72 (6.61%)
Nov 13, 2026, 4:00 PM EST - Market closed

Fennec Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
410263174303252114
Market Cap Growth
89.49%51.48%-42.68%20.14%120.31%-40.49%
Enterprise Value
36226016531624795
Last Close Price
11.627.706.3211.229.604.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
14.0315.8837.3690.856.326.32
PS Ratio
6.185.893.6514.25164.24-
PB Ratio
8.327.41-29.57-26.06-98.137.26
P/TBV Ratio
8.347.41---7.26
P/OCF Ratio
130.28-6.44---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.455.833.4814.88160.94-
EV/EBITDA Ratio
94.63-45.94---
EV/EBIT Ratio
97.25-64.41---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---3.29-2.66-9.690.32
Debt / EBITDA Ratio
--5.37---
Net Debt / Equity Ratio
-0.99-1.041.24-1.52-0.44-1.02
Net Debt / EBITDA Ratio
-12.745.95-2.03---
Asset Turnover
1.000.771.320.790.06-
Inventory Turnover
1.702.871.980.92--
Quick Ratio
5.475.715.712.925.4912.76
Current Ratio
6.116.376.383.565.8013.54
Return on Equity (ROE)
9.07%-65.82%---359.22%-77.36%
Return on Assets (ROA)
3.50%-6.80%4.47%-29.67%-57.21%-39.99%
Return on Capital Employed (ROCE)
5.30%-10.50%6.80%-66.10%-101.20%-83.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
0.51%-3.70%-0.25%-5.30%-9.41%-15.16%
Buyback Yield / Dilution
-28.15%-4.70%-2.71%-1.14%-1.03%-9.71%
SEC Filings: 10-K · 10-Q